Bone Biologics: Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

(marketscreener.com) Bone Biologics Corporation , a developer of orthobiologic products for spine fusion markets, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 781,251 shares of its common stock having an exercise price of $2.43 per share, originally issued in March 2024. The...https://www.marketscreener.com/quote/stock/BONE-BIOLOGICS-CORPORATIO-120796041/news/Bone-Biologics-Announces-Exercise-of-Warrants-for-2-1-Million-Gross-Proceeds-47544179/?utm_medium=RSS&utm_content=20240802